Short interest in Altamira Therapeutics Ltd (NASDAQ:CYTO) increased during the last reporting period, rising from 102.93K to 138.20K. This put 5.21% of the company's publicly available shares short.

Short interest for Altamira Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Altamira Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 67.78K shares traded per day, it would take 2.04 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.